Kelly Klega, MS

Dana-Farber Cancer Institute
Boston, Massachusetts, United States

Disclosure information not submitted.

Presentation(s):

• Paper 18 - PRE-TREATMENT CTDNA BURDEN IS PROGNOSTIC AMONG PATIENTS WITH LOCALIZED EWING SARCOMA: A REPORT FROM THE LEOPARD STUDY

  Thursday, November 14, 2024
  1:45 PM – 3:15 PM PST